Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Patents Awarded for Stem Cell Heart Disease Technologies

U.S. Patent and Trademark Office

A company developing treatments for heart disease using stem cells to regenerate healthy heart tissue received two new patents for techniques supporting its core processes. . . . → Read More: Patents Awarded for Stem Cell Heart Disease Technologies

Appeals Court Backs Broad Institute in Crispr Case

Crispr genome edits illustration

A U.S. appeals court supported the Broad Institute’s claims it invented a separate Crispr technology from University of California, affirming a previous U.S. patent office ruling. . . . → Read More: Appeals Court Backs Broad Institute in Crispr Case

Ultra-Sensitive Nanotech Robot Skin Receives Patent

ultra-sensitive robot skin

Inventors of a system of sensors packaged in a thin film received a patent for their work that enables robotic devices to better sense conditions in the nearby environment. . . . → Read More: Ultra-Sensitive Nanotech Robot Skin Receives Patent

UC-Berkeley Gains U.S. Crispr-Cas9 Patent

Editing DNA

University of California received a patent for its genome editing technology known as Crispr, with the most widely used editing enzyme called Cas9. . . . → Read More: UC-Berkeley Gains U.S. Crispr-Cas9 Patent

Patent Awarded for Nanoparticle Drug, Cannabis Delivery

A delivery technology for therapeutic compounds in nanoscale natural oil particles received a U.S. patent, which the company owning the technology says can be applied to drugs, nutritional supplements, and cannabis-based treatments. . . . → Read More: Patent Awarded for Nanoparticle Drug, Cannabis Delivery

Patents Awarded for Genetic Editing of CAR T-Cells

U.S. patents were awarded to a biotechnology company developing therapies using the genomic editing process known as Crispr to create immune system cells with proteins for attacking cancer cells. . . . → Read More: Patents Awarded for Genetic Editing of CAR T-Cells

Biotech, Pharma Dominate U.S. Academic Patents

In 2016, patents on biotechnology, pharmaceuticals, and medical technologies accounted for 40 percent of all academic patents, with measurement technologies and organic chemistry each getting 7 percent of the total. . . . → Read More: Biotech, Pharma Dominate U.S. Academic Patents

FDA Fast-Tracks Heart Failure Gene Therapy

A biotechnology company developing transfers of healthy genes to treat chronic diseases is receiving an accelerated review of its heart failure therapy from the U.S. Food and Drug Administration. . . . → Read More: FDA Fast-Tracks Heart Failure Gene Therapy

Survey: More Research Patents, Start-Ups in 2016

A survey of universities and other institutions shows the number of patent filings and new start-up companies resulting from federally-funded research climbed in 2016. . . . → Read More: Survey: More Research Patents, Start-Ups in 2016

Patent Awarded for Live Bacterial Acne Treatment

A company developing treatments for disease by restoring the natural balance of bacteria on the skin received a patent for its acne therapy using spray-on live bacteria. . . . → Read More: Patent Awarded for Live Bacterial Acne Treatment